Taiwan
Intelligence de marché des dispositifs médicaux pour Taiwan. Changements réglementaires, concurrents et tendances d'achats.
Signaux récents
A clinical trial is recruiting to evaluate AI-guided diagnosis for high-risk osteoporosis, focusing on smart device integration.
TAIWAN AN I CO.,LTD. has registered a medical device with FDA under product code FNJ.
TAIWAN BIOTECH CO., LTD. has registered a product with FDA under code LPN.
TAIWAN AN I CO.,LTD. has registered a medical device with the FDA under product code CAN.
Taiwan Scientific Corporation has registered three medical devices with product code DXN with the FDA.
DT Research, Inc. has registered two medical devices under product code DSK with the FDA.
MediCapture, Inc. has registered with the FDA under product code FWB, listing one product.
The study evaluated the tBPC optical blood pressure monitoring device's performance against ISO 81060-3:2022 standards.
A completed multinational study evaluated adherence to SAIZEN® using the Easypod™ device in pediatric patients.
A completed study aimed to enhance physical activity and quality of life in hemodialysis patients using wearable devices.
A study compares a novel ultrasonic jaw tracking device to PSG for diagnosing obstructive sleep apnea.
The TipTraQ system for home sleep apnea screening has completed development, involving 240 subjects in Taipei.
A novel device for osteonecrotic femoral head has completed a feasibility study for safety in ONFH patients.
Study shows EMG-driven exoskeleton improves upper extremity function in brain injury patients.
A study in Taiwan is testing wearables for Alzheimer's care, focusing on usability and caregiver stress reduction.
The study compares the efficiency of 3D-printed writing aids for patients with nerve injuries.
A study will assess an innovative inhaler training device's impact on COPD patients' medication accuracy and quality of life.
A completed study reported a rare complication of left atrial appendage perforation during LAAO device deployment.
The HM3 post-market surveillance in Hong Kong and Taiwan was terminated after evaluating advanced heart failure outcomes.
Taiwan Biomaterial Co., Ltd. has registered a medical device with the FDA under product code JCX.